Katarzyna Szklener

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 11

Top Topics

Particulate Matter

Hydrogen Peroxide

Major Depressive Disorder

Top Venues

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Katarzyna Szklener, Anna Rudzińska, Pola Juchaniuk, Zuzanna Kabała, Sławomir Mańdziuk
Ozone in Chemotherapy-Induced Peripheral Neuropathy-Current State of Art, Possibilities, and Perspectives. International journal of molecular sciences 24 (6) (2023)
Anna Rudzińska, Pola Juchaniuk, Jakub Oberda, Jolanta Wiśniewska, Witold Wojdan, Katarzyna Szklener, Sławomir Mańdziuk
Phytochemicals in Cancer Treatment and Cancer Prevention-Review on Epidemiological Data and Clinical Trials. Nutrients 15 (8) (2023)
Katarzyna Szklener, Anna Rudzińska, Pola Juchaniuk, Zuzanna Kabała, Sławomir Mańdziuk
Ozone in Chemotherapy-Induced Peripheral Neuropathy-Current State of Art, Possibilities, and Perspectives. International journal of molecular sciences 24 (6) (2023)
Katarzyna Szklener, Anna Rudzińska, Pola Juchaniuk, Zuzanna Kabała, Sławomir Mańdziuk
Ozone in Chemotherapy-Induced Peripheral Neuropathy-Current State of Art, Possibilities, and Perspectives. International journal of molecular sciences 24 (6) (2023)
Anna Rudzińska, Pola Juchaniuk, Jakub Oberda, Jolanta Wiśniewska, Witold Wojdan, Katarzyna Szklener, Sławomir Mańdziuk
Phytochemicals in Cancer Treatment and Cancer Prevention-Review on Epidemiological Data and Clinical Trials. Nutrients 15 (8) (2023)
Anna Rudzińska, Pola Juchaniuk, Jakub Oberda, Jolanta Wiśniewska, Witold Wojdan, Katarzyna Szklener, Sławomir Mańdziuk
Phytochemicals in Cancer Treatment and Cancer Prevention-Review on Epidemiological Data and Clinical Trials. Nutrients 15 (8) (2023)
Anna Rudzińska, Pola Juchaniuk, Jakub Oberda, Jolanta Wiśniewska, Witold Wojdan, Katarzyna Szklener, Sławomir Mańdziuk
Phytochemicals in Cancer Treatment and Cancer Prevention-Review on Epidemiological Data and Clinical Trials. Nutrients 15 (8) (2023)
Katarzyna Szklener, Adam Michalski, Klaudia Żak, Michał Piwoński, Sławomir Mańdziuk
Ibrutinib in the Treatment of Solid Tumors: Current State of Knowledge and Future Directions. Cells 11 (8) (2022)
Katarzyna Szklener, Marek Mazurek, Małgorzata Wieteska, Monika Wacławska, Mateusz Bilski, Sławomir Mańdziuk
New Directions in the Therapy of Glioblastoma. Cancers 14 (21) (2022)
Katarzyna Szklener, Paulina Chmiel, Adam Michalski, Sławomir Mańdziuk
New Directions and Challenges in Targeted Therapies of Advanced Bladder Cancer: The Role of FGFR Inhibitors. Cancers 14 (6) (2022)
Katarzyna Szklener, Sebastian Szklener, Adam Michalski, Klaudia Żak, Weronika Kuryło, Konrad Rejdak, Sławomir Mańdziuk
Dietary Supplements in Chemotherapy-Induced Peripheral Neuropathy: A New Hope? Nutrients 14 (3) (2022)